[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Discovering if You're High Risk at Diagnosis

Discovering if You're High Risk at Diagnosis image

Discovering if You're High Risk at Diagnosis

Webinar
event Jul 22, 2021 / 01:00PM - 02:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Knowing what type of myeloma you are facing allows you to better fight it. High-risk genetic myeloma often requires a more aggressive treatment regimen than those who are standard-risk patients. Learn from Skyline Dx representatives about their new diagnostic test. This test is one way that newly diagnosed patients can discover their genetic risk and become more empowered to face it head on. Learn with us and come with your questions.


SkylineDx is a biotechnology company, focused on the research & development of molecular diagnostics in oncology and inflammatory diseases. The company is headquartered in Rotterdam (the Netherlands) and complemented with a field medical and scientific affairs team in the US and a CAP/CLIA certified laboratory in San Diego (California). SkylineDx uses its expertise to bridge the gap between academically discovered gene expression signatures and commercially available diagnostic products with high clinical utility, assisting healthcare professionals in accurately determining the type or status of the disease or predict a patient’s response to treatment. Based on test results, healthcare professionals can tailor the treatment approach to the individual patient.

Schedule & Agenda

Event panelist Audrey Burton-Bethke
01:00 PM
Introductions
Audrey Burton-Bethke
Audrey welcomes everyone, shares the event agenda, and introduces our featured speaker.
Event panelist Arjan van Manen
01:05 PM
Presentation
Arjan van Manen
Arjan presents about SkylineDx's new diagnostic test and how it can help newly diagnosed patients discover their genetic risk.
Event panelist Audience
01:35 PM
Q&A
Audience
Ask your questions about SkylineDx's new diagnostic test, the presentation, and related topics.

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Arjan van Manen
Arjan van Manen

Arjan van Manen is the EVP of Business and Commercial Development at SkylineDx BV. He is a strong commercial professional with a track record in Clinical Research, International Marketing Strategy, Market Access, Commercial Excellence Programs, and Business Development. His primary fields of expertise are oncology/ hematology and surgery. He also has experience in the pharmaceutical, medical device, and diagnostic fields. Prior to working at SkylineDx, he worked with organizations including Bristol-Myers Squibb and Takeda Pharmaceuticals. He is fluent in Dutch, German, and English.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Newly Diagnosed group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.